Donat SM - Search Results

1

Natural history of positive urinary cytology after radical cystectomy.

Raj GV, Bochner BH, Serio AM, Vickers A, Donat SM, Herr H, Lin O, Dalbagni G. Raj GV, et al. Among authors: donat sm. J Urol. 2006 Nov;176(5):2000-5; discussion 2005. doi: 10.1016/j.juro.2006.07.049. J Urol. 2006. PMID: 17070236

2

Bladder preservation and continent urinary diversion in T3b transitional cell carcinoma of the bladder.

Cespedes RD, McGuire EJ, Donat SM, Babaian RJ. Cespedes RD, et al. Among authors: donat sm. Semin Urol Oncol. 1996 May;14(2):103-11. Semin Urol Oncol. 1996. PMID: 8734738 Review.

3

Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.

Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Herr HW, et al. Among authors: donat sm. J Urol. 2002 Mar;167(3):1295-8. J Urol. 2002. PMID: 11832716

4

Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder.

Herr HW, Donat SM, Dalbagni G. Herr HW, et al. Among authors: donat sm. J Urol. 2002 Sep;168(3):978-80. doi: 10.1016/S0022-5347(05)64555-7. J Urol. 2002. PMID: 12187203

5

Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence.

Yossepowitch O, Dalbagni G, Golijanin D, Donat SM, Bochner BH, Herr HW, Fair WR, Russo P. Yossepowitch O, et al. Among authors: donat sm. J Urol. 2003 Jan;169(1):177-81. doi: 10.1016/S0022-5347(05)64062-1. J Urol. 2003. PMID: 12478130

6

Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer.

Donat SM, Bayuga S, Herr HW, Berwick M. Donat SM, et al. J Urol. 2003 Nov;170(5):1777-80. doi: 10.1097/01.ju.0000091803.35049.da. J Urol. 2003. PMID: 14532774

7

Evaluation and follow-up strategies for superficial bladder cancer.

Donat SM. Donat SM. Urol Clin North Am. 2003 Nov;30(4):765-76. doi: 10.1016/s0094-0143(03)00060-0. Urol Clin North Am. 2003. PMID: 14680313 Review.

8

Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.

Sharma P, Gnjatic S, Jungbluth AA, Williamson B, Herr H, Stockert E, Dalbagni G, Donat SM, Reuter VE, Santiago D, Chen YT, Bajorin DF, Old LJ. Sharma P, et al. Among authors: donat sm. Cancer Immun. 2003 Dec 18;3:19. Cancer Immun. 2003. PMID: 14680360

9

Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm.

Donat SM, North A, Dalbagni G, Herr HW. Donat SM, et al. J Urol. 2004 Feb;171(2 Pt 1):636-9. doi: 10.1097/01.ju.0000103100.22951.5e. J Urol. 2004. PMID: 14713776

10

Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.

Konety BR, Eastham JA, Reuter VE, Scardino PT, Donat SM, Dalbagni G, Russo P, Herr HW, Schwartz L, Kantoff PW, Scher H, Kelly WK. Konety BR, et al. Among authors: donat sm. J Urol. 2004 Feb;171(2 Pt 1):709-13. doi: 10.1097/01.ju.0000108122.36893.5a. J Urol. 2004. PMID: 14713792 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters